Investigator Trial Enrollment Payments Should Get Public Airing - Temple
Executive Summary
A public forum should be held to discuss issues surrounding sponsor payments to clinical investigators for patient enrollment, FDA Office of Medical Policy Director Robert Temple, MD, told the Drug Information Association annual meeting June 28 in Baltimore.
You may also be interested in...
FDA Oversight Of Clinical Trial Investigators Questioned By Rep. Bliley
FDA oversight of clinical trial investigators is questioned by the House Commerce Committee in a July 13 letter to the HHS Inspector General.
FDA Oversight Of Clinical Trial Investigators Questioned By Rep. Bliley
FDA oversight of clinical trial investigators is questioned by the House Commerce Committee in a July 13 letter to the HHS Inspector General.
FDA Re-evaluating Drug Data Generated By Fraudulent Clinical Investigator
FDA is reviewing data related to drug studies conducted by clinical investigator Robert Fiddes, MD, to ensure the safety and effectiveness of products for which he falsified clinical trial data.